Novel Psychoactive Substances: The Razor's Edge Between Therapeutical Potential and Psychoactive Recreational Misuse

Overview

Journal Medicines (Basel)

Specialty Pharmacology

Date 2022 Mar 24

PMID 35323718

Authors

Beatriz Correia

Joana Fernandes

Maria Joao Botica

Carla Ferreira

Alexandre Quintas

Affiliations

Soon will be listed here.

Abstract

Background: Novel psychoactive substances (NPS) are compounds of natural and synthetic origin, similar to traditional drugs of abuse. NPS are involved in a contemporary trend whose origin lies in a thinner balance between legitimate therapeutic drug research and legislative control. The contemporary NPS trend resulted from the replacement of MDMA by synthetic cathinones in 'ecstasy' during the 2000s. The most common NPS are synthetic cannabinoids and synthetic cathinones. Interestingly, during the last 50 years, these two classes of NPS have been the object of scientific research for a set of health conditions.

Methods: Searches were conducted in the online database PubMed using boolean equations.

Results: Synthetic cannabinoids displayed protective and therapeutic effects for inflammatory, neurodegenerative and oncologic pathologies, activating the immune system and reducing inflammation. Synthetic cathinones act similarly to amphetamine-type stimulants and can be used for depression and chronic fatigue.

Conclusions: Despite the scientific advances in this field of research, pharmacological application of NPS is being jeopardized by fatalities associated with their recreational use. This review addresses the scientific achievements of these two classes of NPS and the toxicological data, ending with a reflection on Illicit and NPS control frames.

Citing Articles

Disposition Kinetics of Cathinone and its Metabolites after Oral Administration in Rats.

Sabei F, Khardali I, Al-Kasim M, Shaheen E, Oraiby M, Alamir A Curr Drug Metab. 2024; 25(3):220-226.

PMID: 38752643 DOI: 10.2174/0113892002300638240513065512.

The Designer Drug αPHP Affected Cell Proliferation and Triggered Deathly Mechanisms in Murine Neural Stem/Progenitor Cells.

Roda E, De Luca F, Priori E, Ratto D, Pinelli S, Corradini E Biology (Basel). 2023; 12(9).

PMID: 37759624 PMC: 10525791. DOI: 10.3390/biology12091225.

Colorimetric and fluorescent detection of synthetic cathinones in oral fluid with -aryl BODIPYs and Cu(ii).

Hernandez-Contreras J, Parra M, Gil S, Costero A, Arroyo P, Sancenon F RSC Adv. 2022; 12(44):28580-28585.

PMID: 36330338 PMC: 9583296. DOI: 10.1039/d2ra05188e.

3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs.

Lopez-Arnau R, Camarasa J, Carbo M, Nadal-Gratacos N, Puigseslloses P, Espinosa-Velasco M Front Psychiatry. 2022; 13:990405.

PMID: 36262632 PMC: 9574023. DOI: 10.3389/fpsyt.2022.990405.

Synthetic cannabinoids use in a sample of opioid-use disorder patients.

Alias-Ferri M, Pellegrini M, Marchei E, Pacifici R, Rotolo M, Pichini S Front Psychiatry. 2022; 13:956120.

PMID: 35990071 PMC: 9381952. DOI: 10.3389/fpsyt.2022.956120.

References

Aratani Y . Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function. Arch Biochem Biophys. 2018; 640:47-52. DOI: 10.1016/j.abb.2018.01.004. View

Tournebize J, Gibaja V, Kahn J . Acute effects of synthetic cannabinoids: Update 2015. Subst Abus. 2016; 38(3):344-366. DOI: 10.1080/08897077.2016.1219438. View

Scudamore O, Ciossek T . Increased Oxidative Stress Exacerbates α-Synuclein Aggregation In Vivo. J Neuropathol Exp Neurol. 2018; 77(6):443-453. DOI: 10.1093/jnen/nly024. View

Cardona-Benavides I, de Ramon C, Gutierrez N . Genetic Abnormalities in Multiple Myeloma: Prognostic and Therapeutic Implications. Cells. 2021; 10(2). PMC: 7914805. DOI: 10.3390/cells10020336. View

Simpson E, Brown H . Understanding osteosarcomas. JAAPA. 2018; 31(8):15-19. DOI: 10.1097/01.JAA.0000541477.24116.8d. View

Lichtman A . SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats. Eur J Pharmacol. 2000; 404(1-2):175-9. DOI: 10.1016/s0014-2999(00)00615-4. View

Al-Eitan L, Alhusban A, Alahmad S . Effects of the synthetic cannabinoid XLR-11 on the viability and migration rates of human brain microvascular endothelial cells in a clinically-relevant model. Pharmacol Rep. 2020; 72(6):1717-1724. DOI: 10.1007/s43440-020-00123-0. View

Taschwer M, Weiss J, Kunert O, Schmid M . Analysis and characterization of the novel psychoactive drug 4-chloromethcathinone (clephedrone). Forensic Sci Int. 2014; 244:e56-9. DOI: 10.1016/j.forsciint.2014.09.007. View

Coppola M, Mondola R . Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food". Toxicol Lett. 2012; 211(2):144-9. DOI: 10.1016/j.toxlet.2012.03.009. View

10.

Sofroniew M, Vinters H . Astrocytes: biology and pathology. Acta Neuropathol. 2009; 119(1):7-35. PMC: 2799634. DOI: 10.1007/s00401-009-0619-8. View

11.

Bose S, Cho J . Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases. Arch Pharm Res. 2013; 36(9):1039-50. DOI: 10.1007/s12272-013-0161-z. View

12.

Idris A, van t Hof R, Greig I, Ridge S, Baker D, Ross R . Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors. Nat Med. 2005; 11(7):774-9. PMC: 1430341. DOI: 10.1038/nm1255. View

13.

Mithoefer M, Feduccia A, Jerome L, Mithoefer A, Wagner M, Walsh Z . MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials. Psychopharmacology (Berl). 2019; 236(9):2735-2745. PMC: 6695343. DOI: 10.1007/s00213-019-05249-5. View

14.

Tateiwa D, Yoshikawa H, Kaito T . Cartilage and Bone Destruction in Arthritis: Pathogenesis and Treatment Strategy: A Literature Review. Cells. 2019; 8(8). PMC: 6721572. DOI: 10.3390/cells8080818. View

15.

Van Hove L, Kim K, Arrick D, Mayhan W . A cannabinoid type 2 (CB2) receptor agonist augments NOS-dependent responses of cerebral arterioles during type 1 diabetes. Microvasc Res. 2020; 133:104077. PMC: 7704564. DOI: 10.1016/j.mvr.2020.104077. View

16.

Gurley S, Abidi A, Allison P, Guan P, Duntsch C, Robertson J . Mechanism of anti-glioma activity and in vivo efficacy of the cannabinoid ligand KM-233. J Neurooncol. 2012; 110(2):163-77. DOI: 10.1007/s11060-012-0958-5. View

17.

Kyle R, Gertz M, Witzig T, Lust J, Lacy M, Dispenzieri A . Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003; 78(1):21-33. DOI: 10.4065/78.1.21. View

18.

Tsang C, Giudice M . Nabilone for the Management of Pain. Pharmacotherapy. 2016; 36(3):273-86. DOI: 10.1002/phar.1709. View

19.

Brunt T, Poortman A, Niesink R, van den Brink W . Instability of the ecstasy market and a new kid on the block: mephedrone. J Psychopharmacol. 2010; 25(11):1543-7. DOI: 10.1177/0269881110378370. View

20.

Gawel S, Wardas M, Niedworok E, Wardas P . [Malondialdehyde (MDA) as a lipid peroxidation marker]. Wiad Lek. 2005; 57(9-10):453-5. View